Abstract
Structure-activity relationships developed from work with peptide based fibrinogen receptor antagonists have been successfully applied to the development of simple and highly potent nonpeptide agents of the same class.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have